Skip to content

The effect of vitamin C supplementation in the last month of pregnancy on neonatal bilirubin level

The effect of vitamin C supplementation in the last month of pregnancy on neonatal bilirubin level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091114002709N47
Enrollment
144
Registered
2018-03-11
Start date
2018-05-22
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice of infants. Neonatal jaundice, unspecified

Interventions

Intervention 1: Intervention group: Use 500 mg Vitamin C supplement /manufactured by Oswah Pharmaceutical Company / Daily / From the beginning of the 35th week to the end of pregnancy. Intervention 2:

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Being on the 34th week of pregnancy Single pregnancy Willingness to participate in research and signing consent Age range 20 to 40 years

Exclusion criteria

Exclusion criteria: pregnancy-related illnesses such as gestational diabetes, gestational hypertension, or hypothyroidism in pregnancy Having severe anemia Hepatic Diseases Renal diseases birth history of premature and low birth weight Family history of favism lactation at the same time as pregnancy use of aspirin and anticoagulants smoking

Design outcomes

Primary

MeasureTime frame
Neonatal blood bilirubin level. Timepoint: Fifth day after birth. Method of measurement: A blood sample of the heel is used to determine the level of bilirubin. This test will be based on light irradiation and turbodometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzad Shidfar

Iran University of Medical Sciences

shidfar.f@iums.ac.ir+98 21 8862 2755

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026